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Abstract
The COX7A2L (Supercomplex Assembly Factor I, SCAFI) protein has been proposed to be
a mitochondrial supercomplex assembly factor required for respirasome (supercomplex
containing complexes I, III, and IV) formation. In the C57BL/6 mouse strain a homozygous
in-frame 6-base-pair deletion in the COX7a2l/SCAF1 gene resulting in unstable protein
and suggesting loss of function was previously identified. The loss of SCAFI was shown
to impede respirasome formation, a major concern for the use of C57BL mouse strains in
mitochondrial research. In contradiction, another recent study suggested that supercomplex
formation is independent of SCAFI isoforms. We investigated whether SCAFI isoform
status affected the disease severity and supercomplex formation in the liver of Bcs1lc.232A>G
knock-in mice with incomplete complex III assembly. In homozygotes (Bcs1lG/G) of mixed
(C57BL/6:129/Sv) genetic background, the lifespan was similar in mice with wild-type
SCAFI allele and in those homozygous (SCAFIshort/short) for the deleted SCAF1 variant
(34±3 days; n = 6 vs. 32±2 days; n = 7, respectively). SCAFI heterozygosity (SCAFIlong/short)
resulted in decreased SCAFI protein but respirasome assembly was unaffected. Congenic
(C57BL/6) mice were of the genotype SCAFIshort/short and had no detectable SCAFI protein.
In their liver mitochondria, respirasome composition was altered as compared to mixed
background mice. Complex IV was mainly present as monomers and dimers, and only low
amounts were found in combination with complex I and complex III or with precomplex III.
The main supercomplex in the liver mitochondria of C57BL/6 mice comprised only com-
plexes I and III. In conclusion, in liver mitochondria of C57BL/6 mice, supercomplexes had
markedly reduced amount of, but were not completely depleted of, complex IV, supporting a
role for COX7A2L/SCAFI in supercomplex assembly. However, the disease progression of
the Bcs1l mutant mice was unrelated to SCAFI isoforms and supercomplex composition,
suggesting that other genetic factors contribute to the different survival in the different
genetic backgrounds.
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Introduction
Mitochondrial respiratory chain (RC) consists of four complexes (CI-CIV), which use the
energy of electron transport to generate a proton gradient that drives ATP synthesis by the
ATP synthase (complex V, CV). The presence of larger conglomerates (supercomplexes) of the
RC complexes was first suggested in 2000 [1] and has been supported by several other studies.
The RC is considered a dynamic apparatus composed of both individual complexes and their
association into supercomplexes, which usually are combinations of CI together with CIII or
with both CIII and CIV (the so called respirasome) or CIII with CIV [2]. Supercomplex forma-
tion requires the presence of cardiolipin [3, 4] and specific assembly factors that have been
identified both in yeast [5–7] and mammals [8, 9]. Supercomplexes are enzymatically active
[2] and influence the efficacy of the RC [9].
COX7A2L, also named SCAFI (Supercomplex Assembly Factor I) has been suggested to be
indispensable for the inclusion of CIV in supercomplexes [9]. Two variants of the SCAFI gene and
protein were found in commonly used laboratory mouse strains. In C57BL/6 mice, the gene har-
bors a six-base-pair in-frame region deletion encoding a shorter (111 amino acids), unstable pro-
tein, whereas full length SCAFI protein (113 amino acids) is present in the 129/Sv strain having the
wild-type SCAFI gene [9]. In comparison to respirasomes containing CIV, respiration in liver
mitochondria lacking CIV in supercomplexes due to the deletion in SCAFI was slightly higher
with substrate for only CI (pyruvate and malate) or CII (succinate), but there was no difference
when both substrates were combined. The study suggested that supercomplex formation might
have important effects on the phenotype of mouse disease models [9]. A contradictory study found
that CIV was present in supercomplexes and RC function was normal in mitochondria of wild-
type C57BL/6 mice with short SCAFI alleles [10]. It is not known whether the short/short genotype
has an effect on the phenotype and disease progress in mouse models of RC complex deficiencies.
We set out to investigate if the SCAFI variants modify disease severity and supercomplex
formation in liver mitochondria in mice with mitochondrial hepatopathy due to CIII defi-
ciency. Our knock-in mouse model harbors the same point mutation (Bcs1l c.232A>G, p.
S78G) that in humans causes the GRACILE syndrome, a neonatal lethal mitochondrial disor-
der presenting with fetal-onset growth restriction and hepatopathy [10]. The homozygous
mutation results in decreased incorporation of Rieske iron-sulfur protein into CIII and
thereby in CIII deficiency in both humans and mice [11, 12]. The main supercomplex in liver
mitochondria of these homozygous mice contains CI, precomplex III without Rieske iron-sul-
fur protein and a small amount of fully assembled CIII [13]. The majority (95%) of mutant
mice of mixed (129/Sv:C57BL/6) genetic background develop symptoms before postnatal day
40 (P40), while a minority (5%) develop no other symptoms than growth restriction until P70-
165 [12]. In congenic mice backcrossed to the C57BL/6 strain, however, the disease progres-
sion is more rapid resulting in lethality before P30. We previously reported that, in liver mito-
chondria of the mutant mice of the C57BL/6 background, CIV was not conclusively found in
supercomplexes [13]. This suggests that the strain carries the deleted SCAFI variant, which
may cause loss of CIV from supercomplexes. We hypothesize that the difference in survival of
the Bcs1l mutant mice between the two different genetic backgrounds might be ascribed to dif-
ferences in supercomplex formation and thus respiration efficiency.
Material and Methods
Animal experiments
Mixed background (129/Sv:C57BL/6) mice harboring the Bcs1lc.232A>G mutation [12] were
backcrossed for 10–12 generations to achieve mutant mice in congenic C57BL/6 (substrain
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C57BL/6NCrlLtcf) background [13]. Sick homozygous (Bcs1lG/G) mice and their littermate wild-
type (Bcs1lA/A) or heterozygous (Bcs1lA/G) control animals of both strains were compared with
129/Sv wild-type mice. The animals were maintained on rodent diet (Labfor R34, Lactamin,
Stockholm, Sweden) and water ad libitum in a vivarium with 12 h light/dark cycle at 22˚C. After
weaning at 21 days of age, the animals were observed daily and weight was monitored 2–5 times
a week. A health score was developed based on six typical behavioral characteristics: waddling
gait, reduced curiosity, lack of movement in the cage, appearance of kyphosis, deterioration of
balance and loss of grip strength. Each item was scored from zero to two (0 for normal, 1 for
slight abnormality and 2 for clear abnormality). When weight gain was decreased compared to
the matched littermate control wild-type (or heterozygous) mouse, scoring was performed in
connection with the weighing procedure. When the score was7/12 or no weight gain occurred,
the animals were considered as having end-stage disease and were sacrificed to prevent sponta-
neous death. No unexpected deaths occurred in the litters studied. The researchers were unaware
of the SCAFI genotype during the entire lifespan. Bcs1lG/G mice of mixed genetic background
homozygous for the short SCAFI allele were chosen from different litters as those with the long
allele to exclude risk of selection bias for an earlier sacrificing time point for the second (or
third) Bcs1lG/G animal in the litter. The animals were sacrificed by cervical dislocation without
premedication to minimize handling. Liver tissue samples were collected immediately after
sacrificing for histology, mitochondrial isolation and snap-freezing.
Ethics statement
Animal experiments were performed according to national guidelines with the approval of the
Lund regional animal research ethics committee (permissions M253-08, M245-11). All efforts
were taken to ameliorate suffering.
Genotyping for supercomplex assembly factor I (SCAFI)
DNA isolated from tail biopsies was used for detection of SCAFI variants (long and short) by
polymerase chain reaction (PCR), using primers P1 (5´- CTTTCTTGCTTTGCAGAAGGC-3´)
and P2 (5´GAAGGCCTCGTTTCAGGTGG-3´) [9] and Taq polymerase from Fermentas
GmbH, St. Leon-Rot, Germany. The PCR products were analyzed on 12% polyacrylamide gels.
Isolation of mouse liver mitochondria and purification of complexes
Mouse liver samples were obtained from the three animal strains (129/Sv:C57BL/6, congenic
C57BL/6NCrlLtcf and wild-type 129/Sv). Mitochondria were isolated from tissue homoge-
nates by sequential centrifugation including density purification on 19% Percoll (GE Health-
care, Amersham, UK) as previously described [12]. Isolated mitochondria were stored at
-80˚C. They were used for CIII activity measurements with ubiquinol as electron donor in a
spectrophotometric assay [12]. Mitochondrial complexes and supercomplexes were extracted
from isolated mitochondria by incubation with 0.8% digitonin (Sigma Aldrich, Stockholm,
Sweden) as previously described [13].
SDS-PAGE, BNGE and 2D-BNGE
For detection of SCAFI protein, liver tissue lysates were run on a 12% SDS-PAGE. RC com-
plexes and supercomplexes were assessed with blue native gel electrophoresis (BNGE) or
2-dimensional BNGE (2D-BNGE) as described earlier [13]. Proteins separated by SDS-PAGE,
BNGE or 2D-BNGE were blotted onto polyvinylidine difluoride membranes using iBlotTM
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equipment (Invitrogen, Carlsbad, CA, USA). Membranes were blocked in PBS supplemented
with 0.05% Tween 20 and 5% dry milk for subsequent antibody incubation.
The SCAFI protein was detected by an antibody against COX7A2L (66062-1-lg, Proteintech
Group, USA). Most antibodies directed against respiratory chain complex subunits were
obtained from MitoSciences (Eugene, Oregon, USA); for CI subunit NDUFA9 (MS111) was
used, for CIII subunits Core1 (MS303) and RISP (MS305), for CIV subunit I (COX1, MS404)
and subunit Va (MS409). An antibody directed against ETFAα (MS782) was used as loading
control. An antibody detecting the CI subunit NDUFV1, which is incorporated in the complex
at the final assembly stage, was obtained from Sigma Aldrich (Stockholm, Sweden). Primary
antibodies were detected by incubation with HRP-coupled goat anti-mouse secondary anti-
body (DAKO Cytomation, P0447). Membranes were developed with ECL plus (GE Health-
care, Amersham, UK). For detection of COX1 a prolonged exposure time was used (up to 10
min). The 2D-BNGE membranes were first probed with RISP and COX1 antibodies, thereafter
stripped with Re-blot Plus antibody stripping solution (Millipore, Temecula, CA, USA), then
probed with antibody against Core1 and after a second stripping probed with antibody against
NDUFA9.
Statistics
The group differences in lifespan were analyzed with Student´s t-test. A p value below 0.05 was
considered statistically significant. The values are presented as mean and SD. Differences in
2-D-BNGE immunoblots were calculated with densitometry.
Results
Disease progression in homozygotes (Bcs1lG/G) of different genetic
backgrounds is not related to SCAFI isoforms
Health status in homozygous mutant (Bcs1lG/G) and wild-type (Bcs1lA/A) littermate control
mice of mixed background (129/Sv:C57BL/6) [12] was compared with Bcs1lG/G and Bcs1lA/A
of backcrossed C57BL/6 background [13] and with 129/Sv wild-type mice. The homozygous
mutant mice in both genetic backgrounds developed normally until P21, where after their
growth slowed down [12, 13]. Because of imminent lethality and decreasing weight the back-
crossed Bcs1lG/Gmice were sacrificed by P30, whereas those of mixed background were eutha-
nized by about P40. Histopathological analyses of the liver of backcrossed C57BL/6 Bcs1lG/G
mice displayed early-stage hepatopathy and centrilobular glycogen depletion (S1 Fig) some-
what more severe than in the mixed background strain [12]. In BNGE of isolated mitochon-
dria from liver of homozygotes, CIII was typically present as a pre-complex [13] because of the
Bcs1l mutation (Fig 1).
SCAFI genotyping showed that 129/Sv wild-type mice were homozygous for the long allele
encoding a 113-amino acid protein, whereas mice of the C57BL/6 backcrossed strain were
homozygous for the short allele predicting a 111-amino acid protein that was undetectable on
Western blots (Fig 2A and 2B). Mice of mixed background were either heterozygous for the
two alleles (Fig 2A) or homozygous for the short one. The 113 amino acid SCAFI protein was
detected in 129/Sv wild-type (homozygous for long SCAFI, Fig 2B). The backcrossed C57BL/6
strain lacked detectable SCAFI protein, whereas the 129/Sv:C57BL/6 strain heterozygous for
long SCAFI had detectable SCAFI protein but lower expression than in 129/Sv wild-type mice.
The typical 1-month lifespan of the homozygotes in mixed background was not related to
SCAFI isoform status (Table 1). Exceptionally long survivors were one homozygote with SCA-
FIlong/short (105 days, weight 13.1 g, 47% of littermate control) and two with SCAFIshort/ short
SCAFI and Supercomplex Formation in Complex III Deficiency
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(60 days, 10.6 g, 54% and 170 days 22.2 g, 59%), respectively. The CIII activity was similar in
wild-type animals of both strains and the decrease in activity in the mutant mice was also simi-
lar at end-stage disease in both genetic backgrounds (activity level 10–20% of littermate con-
trols, data in Supplement S1 Table).
Long SCAFI isoform is required for normal CIV assembly into
supercomplexes
In BNGE of liver mitochondria, four different supercomplexes were identified in mixed back-
ground and 129/Sv wild-type mice (Fig 1). Both in BNGE (Fig 2C) and 2D-BNGE (Fig 3) anal-
yses, the most prominent supercomplex contained CI/CIII2, detected by antibodies against
subunits NDUFV1 and Core1 (Fig 2C). The antibody against subunit Va detected CIV mainly
as free monomer and dimers (Fig 2C). In BNGE of mitochondria from 129/Sv mice (SCAFI-
long/long) and mixed background wild-type mice (SCAFIlong/short), CIV was part of supercom-
plexes CIII2/CIV and CI/CIII2/CIV, whereas in the C57BL/6 background (SCAFIshort/short)
these supercomplexes were not detected with the antibodies used (Fig 2C). In mixed back-
ground homozygous (Bcs1lG/G) mice, pre-complex III2 containing Core1, but not Rieske sub-
unit and thus of a smaller molecular weight than CIII, was found together with CIV in CIII2/
CIV supercomplex (Fig 2C).
As we did not convincingly find CIV in supercomplexes in backcrossed animals by BNGE,
we performed 2D-BNGE runs to separate subunits of the complexes and investigate the pres-
ence of CIV. CI and CIII were abundant in supercomplexes in all three strains, whereas CIV
was mainly present in free form as monomers and dimers (Fig 3). In the 129/Sv wild-type
mice, CIV was detected both together with CIII (CIII2/CIV) and in the CI/CIII2/CIV super-
complexes. In wild-type mice of mixed background (SCAFIlong/short), CIV was also present in
CIII2/CIV and CI/CIII2/CIV supercomplexes (Fig 3B), but in Bcs1lG/G homozygotes dimin-
ished amounts of CIV were detected in the CI/CIII2/CIV supercomplex. In CI/CIII2/CIV the
RISP antibody revealed a strong band but not in CIII2/CIV (as shown by Core1 antibody) sug-
gesting that pre-CIII and CIV are associated in the CIII2/CIV supercomplex in these
Fig 1. BNGE analysis. Comparison of isolated liver mitochondria from Bcs1l mutant homozygotes (G/G) and
wild-types (A/A) of 129/Sv:C57BL/6 mixed background (MB), C57BL/6 backcrossed (BC) strain and the 129/
Sv strain. Four supercomplex bands (SC) are visible in wild-type animals in MB and 129/Sv strains, one of the
bands not found in C57BL/6 animals. In homozygotes (G/G) in both MB and BC strains, free complex I (CI) is
more abundant than in wild-type animals (A/A), and free complex III (CIII) is only present as a pre-complex
(PreCIII2).
doi:10.1371/journal.pone.0168774.g001
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Fig 2. SCAFI allele status and its effect on supercomplex assembly in Bcs1l mutant mice (G/G) of
different genetic backgrounds. Wild-types (A/A) and Bcs1l mutant mice (G/G) of 129/Sv:C57BL/6 mixed
background (MB) and C57BL/6 background (BC) were analyzed and a wild-type of the 129/Sv strain (129/Sv)
was used as a control. (A) Agarose gel electrophoresis of SCAFI genotyping PCR products showing the long
(SCAFI long) and short (SCAFI short) alleles in mice of different genetic backgrounds. (B) Western blot
analysis of SCAFI protein and ETFAα (electron transfer flavoprotein alpha) as loading control in liver tissue
lysate showing reduced level of SCAFI protein in mixed background (MB) mice and no detectable protein in
C57BL/6 mice (BC). (C) Respiratory chain complexes and supercomplexes were separated on BNGE and
detected by Western blot using the antibodies indicated. Molecular weights are indicated on the right. Note
that the COX1 antibody required an extended exposure time for detection in supercomplexes. ETFAαwas
used as a loading control. NDUFV1 antibody shows in mutant (G/G) mice abundant free CI, in all mice CI/
SCAFI and Supercomplex Formation in Complex III Deficiency
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homozygotes (Fig 3B). With a longer exposure time the COX1 antibody detected a faint band
in CI/CIII2/CIV area both in congenic wild-type (Bcs1lA/A) and homozygous (Bcs1lG/G) mice
(Fig 3C). Further, a similar faint COX1 band was detected for CIII2/CIV, but it was not co-
localized with the Rieske subunit in the Bcs1lG/G homozygous mouse (Fig 3C, S2 Fig), suggest-
ing that this supercomplex contained pre-complex III like in homozygotes of mixed back-
ground (Fig 3B).
Mitochondria from Bcs1lG/Gmice of both mixed and congenic background displayed an
additional supercomplex detected with RISP and NDUFA9 larger than CI/CIII2/CIV.
The uncropped blots of the membranes probed with Core1 antibody after the first stripping
to remove RISP and COX1 antibodies show the alignment of Core1 and RISP, and that COX1
antibody reactivity has been removed from the area positive for NDUFA9 antibody (S2 Fig).
Discussion
Our hypothesis that the longer survival of homozygous Bcs1l mutant mice in mixed back-
ground would be related to presence of long SCAFI isoform was not supported. Previously, we
have shown that respiration as assessed using Oroboros Oxygraph is similar in homozygotes
of C57BL/6 strain [13] and in those of mixed background [12], both when using substrates for
CI and CII. Thus, we have not found any functional differences in RC between mutants in the
different genetic backgrounds. SCAFI may not be crucial for mitochondrial function since
knockout of the SCAFI gene (Cox7rp) resulted in a mild phenotype with decreased COX activ-
ity and ATP production in muscle, but the mice were otherwise healthy and fertile [8].
Supercomplex formation has been suggested to modify respiratory chain activity in
response to the metabolic state and energy need of the organism [9]. Thus, increased metabolic
pressure such as that in the Bcs1lG/Gmice with progressive CIII deficiency might be compen-
sated by increased supercomplex assembly. In line with data from mouse liver mitochondria
showing that SCAFI is needed for CIV incorporation into supercomplexes [9], we found abun-
dant CIV in the combinations CIII2/CIV and CI/CIII2/CIV only in mice of mixed back-
ground with the long SCAFI allele, but very little in mice homozygous for the short allele.
CIII2, and in wild-type MB and 129/Sv that this is overlapping with the band for CI/CIII2/CIV. Core1 shows pre-
CIII2 and CIII2, and RISP fully assembled CIII2 indicating presence of CIII in all supercomplexes of 129/Sv and
wild-type MB animals, but mainly in supercomplex CI/CIII2 in mutant (G/G) mice of both backgrounds. CIV
antibody shows a clear band in respirasome in 129/Sv mouse, but of varying intensity in MB wild-type mice in
relation to the loading control (ETFAα).
doi:10.1371/journal.pone.0168774.g002
Table 1. SCAFI genotype and age at end-stage disease (age at sacrificing) of homozygous (Bcs1lG/G)
mice in different genetic backgrounds.
Mouse strain of Bcs1lG/G SCAFI genotype Age at sacrificing (days)
Typical agea Long survival
129/Sv:C57BL/6 long/short 34 ± 3 (n = 6b) 105 (n = 1)
129/Sv:C57BL/6 short/short 32 ± 2 (n = 7c) 60; 170 (n = 2)
C57BL/6 short/short 28 ± 1d (n = 8) None
aValues are mean ± SD
bIncludes one mouse with long/long genotype
cThe mice with short/short genotype are from different litters than those with long/short
dThe lifespan of C57BL/6 homozygotes was significantly (calculated with t-test) shorter than that of 129/Sv:
C57BL/6 mixed genetic background with long/short (p<0.001) and short/short (p = 0.003) SCAFI.
doi:10.1371/journal.pone.0168774.t001
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Fig 3. 2D-BNGE with Western blot detection showing supercomplex composition in mitochondria of the
three mouse strains studied. Antibodies against CIII (RISP) and CIV (COX1) subunits were initially used and
after stripping the antibody against Core1. After a second stripping the antibody against CI (NDUFA9) was used.
Supercomplexes are indicated by vertical boxes. (A) In the 129/Sv wild-type mouse, CIV was present in two
supercomplexes. (B) Both CIV containing supercomplexes were present in wild-type mice (Bcs1lA/A) of 129/Sv:
C57BL/6 mixed background strain (MB with SCAFIlong/short). In mutant (Bcs1lG/G) mice, CIV was decreased in the
respirasome CI/CIII2/CIV and more abundant in the formation of pre-CIII2/CIV. (C) In backcrossed (BC) C57BL/6
congenic strain (with SCAFIshort/short), CIV was very faintly present in supercomplexes even when exposure time
was increased compared to MB. In homozygotes (G/G) of both backgrounds, a CI2/CIII2 supercomplex was found
and free CI was more abundant than in wild-type (assessed with densitometry: 26% in 129/Sv, 27% vs. 49% in
MB and 48% vs. 56% in BC wild-type and homozygotes, respectively), as also shown in Fig 2.
doi:10.1371/journal.pone.0168774.g003
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Ikeda et al. have shown that loss of function of Cox7rp (synonym for Cox7a2l and SCAFI) in
the C57BL/6 background affected mainly the CI/CIII2/CIV supercomplex formation, whereas
the CIII2/CIV supercomplex was still detectable in muscle mitochondria [8]. These differences
might be attributed to tissue-specific differences between liver and muscle mitochondria.
Using radiolabelled precursor of the COX6a subunit of CIV, the pattern of supercomplexes
was found to be similar in C57BL/6J (homozygous for the short SCAFI allele) and control liver
mitochondria (with long SCAFI allele), but the amount of CIV was clearly less in supercom-
plexes in C57BL/6J mitochondria [10]. Our BNGE conditions have been carefully titrated and
were similar to theirs in the experiments presented here. Thus, we consider our findings to be
representative for liver mitochondria of the C57BL/6 mouse strain. It remains to be elucidated
whether other interacting factors modify the effect of SCAFI on supercomplex formation. In
Bcs1l mutant mice, the accumulation of pre-CIII in mitochondria of both genetic back-
grounds, as a result of the progressive Rieske protein depletion [13], influenced supercomplex
formation. The small amount of fully assembled CIII2 was associated with the CI/CIII2/CIV
respirasome suggesting a preferred rearrangement towards CI/CIII2 if not fully assembled.
Supercomplexes have been reported to be sensitive to reactive oxygen species (ROS) [14]. Dis-
ruption of the supercomplex CI/CIII2 results in enhanced ROS production from CI [15].
Thus, the supercomplex rearrangement might prevent generation of ROS from CI and could
explain why elevated ROS levels were detectable only in end-stage disease in Bcs1lG/G mice of
mixed genetic background [16].
In conclusion, we show that COX7a2L/SCAFI is important for formation of respiratory chain
supercomplexes containing CIV. However, in mice with short SCAFI isoforms, a small amount
of CIV was still detectable in supercomplexes. Whether this formation is the result of only partial
loss of function of SCAFI by the 6-base-pair deletion (hypomorphic allele) or to other factors
contributing to the assembly remains to be resolved. In a recent transomics study on tens of
wild-type mouse strains, the COX7a2L/SCAFI protein was found to be involved in the formation
of many CIV containing supercomplexes, but the influence varied between tissues [17]. The
presence of pre-CIII in our homozygous mutant mice with defective Rieske iron sulfur protein
incorporation influenced also supercomplex configuration. In our viable mitochondrial disease
model, the loss of CIV in the respirasome-supercomplex did not have a detectable functional
effect, in contrast to the previous study on wild-type animals [9]. As for the functional conse-
quences of SCAFI loss-of-function our results support the findings of the Larsson group [10]
and of the Inoue group [8]. Thus, although SCAFI clearly affects supercomplex assembly, it does
not seem to be crucial for RC function in the liver mitochondria of Bcs1l mutant mice.
Supporting Information
S1 Fig. Liver histology. Hematoxylin-eosin (HE) staining showed normal liver architecture in
control (A/G) mice (A, C) and localized hepatocyte hypertrophy with more eosinophilic
appearance due to glycogen depletion in the mutant (G/G) livers of mixed 129/Sv:C57BL/6
background at P34 (B). In the mutant livers (G/G) of backcrossed C57BL/6 background, signs
of early-stage hepatopathy with expansion of portal areas (densely packed blue nuclei) and
incipient fibrosis were observed at P29. Increased number of cells with double nuclei, and scat-
tered strongly eosinophilic (darker red) and degenerating (pale ballooned cytoplasm) hepato-
cytes were present (D). Periodic acid-Shiff (PAS) staining showed normal non-fasted glycogen
(purple staining) distribution in control (A/G) mice of both backgrounds (E, G) and typical
patchy glycogen depletion in the mutant mice (G/G, F, H) with more prominent periportal
depletion in the backcrossed C57BL/6 mice (H). Original magnification 200X.
(TIF)
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S2 Fig. Uncropped panels of 2D-BNGE. The membranes were initially probed with RISP and
COX1 antibodies and after stripping probed with Core1 antibody. COX1 antibody was almost
completely removed from SC. In BC animals the main supercomplex (SC) formation is with
CI and CIII with small amount of CIV, containing both pre-CIII2 and fully assembled CIII2 in
homozygous mutant mice (G/G).
(TIF)
S3 Fig. Survival curves. Age at sacrificing of homozygotes (Bcs1lG/G) of mixed genetic back-
grounds with long/short or short/short SCAFI alleles and of congenic C57BL/6 strain with
short/short alleles.
(TIF)
S1 Table. Data on animals included in the study.
(PDF)
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